消毒副产品（DBPs）已受到监管 在成品饮用水中饮用25年以上 年。本文改编自克拉克奖讲座 作者在演讲中分析了几个方面 与DBP监管和管理的科学和政策相关 控制并强调正在破坏 公共卫生保护。这些缺陷包括 流行病学研究的局限性 针对DBP和 导致了他们的监管以及监管体系的缺陷 美国环境保护部的监管方法 在过去的一个季度里，该机构一直遵守这一规定- 100年 此外，供水商也相对稳定 在控制DBP形成的方法上目光短浅 必须着眼于长期管理和 治疗方法。根据他31年的经验 通过对这一主题的研究，作者开发了具体的 改善DBP健康影响的建议 研究、监管方法和控制 策略。包括24个参考文献、图表。

Disinfection byproducts (DBPs) have been regulated in finished drinking water for more than 25 years. This article, adapted from the Clarke Prize Lecture delivered by the author, analyzes several aspects related to the science and policy of DBP regulation and control and highlights deficiencies that are undermining public health protection. These deficiencies include limitations in the epidemiological studies that were conducted on the adverse health effects of DBPs and led to their regulation as well as shortcomings in the regulatory approach that the US Environmental Protection Agency has adhered to over the past quarter-century. In addition, water suppliers have been relatively shortsighted in their methods of controlling DBP formation and must look to long-term management and treatment methods. Drawing on his 31 years of research on the subject, the author has developed concrete suggestions for improving DBP health effects studies, regulatory approaches, and control strategies. Includes 24 references, figures.